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Summary
The effects ofcyclosporin A (CsA) on influencing the intrathymic clonal deletion were investigated
by using our established thymic stromal cell clone with capacities to express la antigens and
to produce a unique T cell growth factor. The following were revealed: (a) T cell clone with
a given specificity was killed on the la+ stromal cell monolayer in the presence of the relevant
antigens, a process depending on T cell receptor (TCR) stimulation; and (b) CsA allowed the
T cell clone to continuously proliferate even during TCR stimulation by virtue of the stromal
cell-derived T cell growth factor. This paper describes an in vitro model of a mechanism by
which CsA is responsible for the generation of normally "forbidden" T cell clones.
C
yclosporin A (CsA) is a powerful immunosuppressive
drug that is widely used in alleviating allograft rejec-
tion by inhibiting lymphokine production of Th cells (1).
CsA is also effective in preventing GVHD secondary to allo-
geneic marrow transplantation (2), as well as several autoim-
mune diseases (3, 4). paradoxically, irradiatedhosts transplanted
with syngeneic or autologousbone marrow and then treated
with, and withdrawn from, CsA develop autoimmunity as
characterized by a GVHD-like syndrome (5-8). These studies
have suggested that CsA interferes with the processes of in-
trathymic T cell development, allowing the escape of autoreac-
tive T cells (6).
There have been advances in the delineation of roles of the
thymic microenvironment in T cell maturation and reper-
toire selection (9, 10). We have also established a thymic
stromal cell clone MRL104.8a (11) exhibiting two major fea-
tures: potential to express class I and class II H-2 antigens
and production of a unique T cell growth factor designated
as thymic stroma-derived T cell growth factor (TSTGF)
(11-13). We observed that: (a) MRL104.8a monolayer can
promote the growth ofantigen-specific Th clones by producing
the TSTGF when the relevant antigen is absent in cultures;
and (b) lethal growth inhibition ofa Th clone is induced when
its TCRs are activated by adding the relevant antigen to the
Ia-expressing monolayer (14). Thus, the dual function ofthis
thymic stromal cell clone represented a model for selecting
the T cell repertoire in the thymus that depends on whether
the antigen receptor for each T cell clone is triggered. This
also permitted us to directly examine the effect of CsA on
the interaction between T lymphocytes and thymic stromal
cells.
Materials and Methods
Thymic Stroma-derived Cell Clone
￿
A thymic stroma-derived cell
clone (MRL104.8a) that has been recently established from MRIr
lpr/1pr mouse thymuses (11) was used.
T Cell Clones.
￿
KLH-specific, I-Ek-restricted Th clone 9-16 and
allo-I-Ek-reactive Th clone 2-13 were kindly provided by Dr. Y
Asano (Tokyo University School of Medicine, Tokyo, Japan) and
Dr. M. Kimoto (Saga Medical School, Saga, Japan), respectively.
Reagents and mAbs.
￿
Recombinant murine IFN-y was provided
by Shionogi Pharmaceutical Co. Ltd., Osaka, Japan. The superna-
tant containing TSTGF was obtained from cultures of the
MRL104.8a thymic stromal cell clone. A semipurified sample of
TSTGF that was free of activities for IIA, IL2, IL3, 11,4, 116,
11,6, and CSFs was prepared as described (11, 12). C&A was from
Sandoz Pharmaceuticals Division (Sandoz Inc., Basel, Switzerland) .
5 mg CsA was dissolved in 0.4 ml ofethanol and 0.1 ml of Tween
80, and RPMI 1640 medium was added to give a total volume of
1 ml. This stock solution was further diluted with the complete
culture medium.
Gamma globulin fractions of hybridoma culture supernatants
producing mAbs against Kk (11-4.1), I-A' (10-2.16), and I-Ek (14-
4-4s) were prepared as described (14).
Culture Media.
￿
DMEM supplemented with 10% FCS, 5 x 10-5
M 2-ME, and gentamycin (50 Wg/ml) was used throughout this
study.
Proliferation Assay. Th clones were cultured on MRL104.8a
monolayer (3,000 rad, X-irradiated) or C3H/He splenic feeder cells
(2,000 rad X-irradiated) in wells of flat-bottomed, 96-well micro-
plates at 37°C in a COZ incubator for 2 d (14). The cells were then
pulsed with 0.5 PCi/well of fH]TdR for 6 h, and the incorpo-
rated radioactivity was measured. Results are shown as the mean
cpm ± SE of triplicate cultures.
Immuno,f luorescence Staining and Flow Microflwrometry (FMF~
￿
The
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as described previously (14) .
Results and Discussion
The MRL104.8a thymic stromal monolayer was allowed
to express class I and II H-2 antigens by exposure to IFN-y
(14) .A KLH-specific Th clone, 9-16, was cultured on Ia-ex-
pressing MRL104.8a monolayer in the absence or presence
of the relevant KLH antigen (Table 1) . The 9-16 Th clone
was supported for thegrowth in the absence ofKLH, whereas
its growth was markedly inhibited in the presence ofKLH,
whichconfirmed the previous observation (14) . This growth
inhibition was ascribed not to a mere reduction of [3H]TdR
uptake by Th clone, but to a striking decrease of Th clone
cell number (cell death) (Fig. 1, A and B) .
Theaddition ofCsAto cultures resulted in complete rescue
of the Th clone from the lethal effect (Table 1). This is also
illustrated in Fig . 1,C andD. Similar killing-rescue patterns
of results were obtained by using the anti-I-Ek-alloreactive
Th done 2-13 (Table 1) . This done, which is capableofprolifer-
atingon IFN-y-unexposedMRL104.8amonolayer to a limited
but detectable extent, was killed on thela-expressingmono-
layer. Such a lethal effect was also preventedby CsA . It should
also be noted that semipurified TSTGF sample could pro-
mote thegrowth of the9-16 Th clone irrespective ofwhether
CsA was included in cultures (Table 1) .
We additionally investigated the effects ofvariousconcen-
trations ofCsA on TSTGF-mediated growth promotion and
lethal growth inhibition ofTh clone. Fig . 2 A shows that
growth promotion of the 9-16 Th clone on the MRL104.8a
monolayercontaining no KLH antigen is not affected by the
Table 1.
￿
CsA Prevents Antigen-stimulated Clottal Elimination
on Thymic Stromal Cell Monolayer
['H]TdR uptake (cpm)t
MRL104.8a monolayers prepared in 96-well microculture plates
were untreated or exposed to 100 U/ml IFN-y[MRL104 .8a
(IFN-y)] . After washing, the monolayers were 3,000 rad X-irradi-
ated before culturing with Th clone (2 x 104/well) . KLH,
40 tog/ml; TSTGF, 1 U/ml .
t Th clone was cultured in the absence (solvent control) or presence
of 100 ng/ml CsA for 2 d .
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Figure 1 .
￿
Phase-contrast micrographs of Th clone cells on an
MRL104.8a monolayer. MRL104.8a monolayers were prepared in 24-
well culture plates and allowed to express la antigens . 9-16 Th clone
(2 x 105/well) was cultured for 4 d at the same concentrations of
KLH and CsA as described at the footnotes of Table 1 . (A) KLH(-)
and CSA(-) ; (B) KLH(+) and CsA(-) ; (C) KLH(-) and CsA(+) ;
(D) KLH(+) and CsA(+) . Note that Th are seen as dark spots since
they are present under stromal cells .
presence of a wide range ofCsA doses . Thesedata are com-
patible with the results that CsA exhibited no suppressing
effect on the TSTGF activity (line 2 of Table 1), as well as
that the production of the TSTGF activity in culture super-
natants was not influenced by thepresence ofCsA (datanot
shown) .
In the presence of aKLH antigen, lethal growth inhibi-
tion of the 9-16 Th clone was again observed, and its lethal
effect was prevented by CsA in a CsA dose-dependent way
A. MRL10a.sa only 9. MAL104.sa-KLH C.lakfaadar " KLN
8 32 128 512 8 32 128 512 8 32 128 512
Concentration of CaA (ng/ml)
Figure 2 .
￿
C&A dose-dependent influences on T cell growth inhibi-
tion or stimulation induced by the respective thymic stromal cells or
splenic APC . (A and B) 9-16 Th clone (2 x 104) was cultured with
or without 20 p,g/ml KLH antigen on MRL104.8a monolayers in
96-well microflates . (C) 9-16 Th clone was cultured with 2 x
105/well of la (C3H/He) spleen cells plus KLH . Each culture con-
tained various concentrations of CsA (" ) or solvent control (O) .
Dashed lines indicate [3H]TdR uptake of Th clone in cultures con-
taining neither control solvent nor CsA .
Th
clone Stimulation* with : CsA (-) CsA (+ )
9-16 - 200(1 .11) 299(1 .10)
VF
O
x
TSTGF 11039(1 .02) 10395(1 .03) E
MRL104.8a(IFN-.y) 9378(1 .21) 10395(1 .03) a
MRL104.8a(IFN-y) + KLH 1661(1 .21) 14793(1 .17)
2-13 - 316(1 .15) 551(1 .23) f
TSTGF 801(1.06) 772(1 .02)
MRL104.8a 2736(1 .06) 2416(1 .05)
MRL104.8a(IFN--y) 899(1 .17) 2456(1 .03)during exposure
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Figure 3.
￿
Effect of CsA on MHC expression of MRL104.8a cells.
MRL104.8a cells were exposed to 50 U/ml rIFN-.y in the absence
(B) or presence (C) of 200 ng/ml C&A for 2 d. MRL104.8a cells that
had been exposed to IFN-.y were cultured in the absence (D) or pres-
ence (E) of C&A for an additional 2 d. Cells were stained with anti-
Kk, anti-I--Ak, or anti-I-E' antibody as described (10).
(Fig. 2 B). In contrast, proliferation of this Th clone was
induced by TCR stimulation with antigen plus I-Ek on
C3H/He spleen cells, and CsA induced a dose-dependent in-
hibition ofTCR-mediated activation (Fig. 2 C). These results
suggest that the rescue of the Th clone from lethal growth
inhibition depends on CsA-induced inhibition of TCR
mediated activation events.
The inhibitory effect ofCsA on TCRmediated activation
events might be explained by considering the possibility that
CsA alters the expression of H-2 molecules on thymic stromal
cells required for forming TCR-stimulating complex (7). To
test this, CsA was added to either of two phases ofculturing,
in which H-2 molecules are induced on MRL104.8a cells by
exposure to IFN-y or in which they decrease after removal
of IFN-y. Fig. 3 illustrates that CsA does not exert its in-
hibiting effect on either the induction or reduction phase of
H-2 antigens.
Thus, our results demonstrate that: (a) CsA blocks the
deletion of Th clone with a given specificity that is other-
wise induced on thymic stromal monolayer; and (b) CsA does
not inhibit either the production ofTSTGF activity by stromal
cells or implementation of its growth-promoting effect.
C&A exerts many ofits effects on T cells via specific inhibi-
tion of TCR-mediated activation (1). In the present model,
CsA induced the rescue ofTh clone from lethal growth inhi-
bition. This rescue observed in the presence ofCsA is provoca-
tively similar to that induced in the presence of antibody to
class II MHC or CD3 to block TCR stimulation (14). Thus,
it is likely that CsA prevents the Th clone from lethal growth
inhibition through interference with TCR-mediated signals.
It has also been reported that CsA reduces the expression of
class II MHC on cellsin the medullary region of the thymus
(7). Whether CsA affects in vivo the expression of class 11
MHC on thymic stromal cellsresponsible for negative selec-
tion is unclear. Irrespective of this, it is evident that the lack
of TCR-mediated signals leads to the failure of deletion of
the relevant T cell clones.
Regarding the effects of CsA on T cell development in
the thymus, two major observations have been reported (15,
16). First, CsA interferes with the differentiation of imma-
ture CD3- - low 4+8+ thymocytes into mature CD3hi' 4+8-
or CD3high 4-8+ cells. Second, CsA induces incomplete de-
letion of potentially autoreactive T cells expressing a high
density of TCR. Taken together, it is likely that CsA blocks
the deletion of autoreactive T cell clones among the small
number of a/(3 T cells that can mature in the presence of
CsA, preventing negative selection (15, 16).
We have proposed that: (a) thymic stromal cells with special-
ized functions (MRL104.8a) are capable of negatively reg-
ulating the growth of the Th clone that is used here as a
model of o:/,3 TCRhigh maturing or mature thymocytes and
(b) that such regulation is dependent on TCR stimulation
(14). The present results, obtained by using a minimal unit
of the thymic stroma that is lethal to antigen-specific T cells
and results in clonal elimination, provide an in vitro model
for explaining the paradox of CsA-induced autoimmunity.
Since our results demonstrate that CsA does not interfere with
the capacity of the thymic stroma to contribute to T cell
proliferation, this model could also account for survival of
thymocytes including autoreactive T cell precursors during
the presence ofCsA in the thymic microenvironment ofCsA-
treated recipients.
We thank Dr. G.M. Shearerfor hiscritical reviewing ofthis manuscript and Miss N. Kawai for herexpert
secretarial assistance.
This work was supportedin part by Grant-in-Aids forScientific Research from theMinistry ofEducation,
Science and Culture, Japan.
Address correspondence to Dr. Hiromi Fujiwara, Biomedical Research Center, Osaka University Medical
School, 1-1-50 Fukushima, Fukushimaku, Osaka, 553, Japan.
Receivedfor publication 3 January 1990 and in revisedform 15 March 1990.
Brief Definitive ReportReferences
1. Shevach, E.M. 1985. Theeffects of cyclosporin A on the im-
mune system. Annu. Reu Immunol. 3:397.
2. Tutschka, P.J., WE. Beschorner, A.C. Allison, W.H. Bums,
andG.W. Santos.1979. Use ofcyclosporin Ain allogeneicbone
marrow transplantation in the rat. Nature (Lond.). 280:148.
3. Bolton, C., G. Allsopp, and M.L. Cuzner. 1982. The effect
of cyclosporin A on the adoptive transfer of experimental al-
lergic encephalomyelitis in the Lewis rat. Clin. Exp Immunol.
47:127.
4. Stiller, C.R., J. Dupre, M. Gent, M.R. Jenner, P.A. Keown,
A. Laupacis, R. Martell, N.W. Rodger, BY Graffenried, and
B.MJ. Wolfe. 1984. Effects of cyclosporin immunosuppres-
sion on insulin-dependent diabetes mellitus of recent onset.
Science (Wash. DC). 223:1362.
5. Glazier, A., P.J. 'I4tschka, E.R.Farmer, andG.W. Santos.1983.
Graft-versus-host diseasein cyclosporin A-treated rats after syn-
geneic and autologous bone marrow reconstitution.J. Exp
Med. 158:1.
6. Sorokin, R., H. Kimura, K. Schroder, D.H. Wilson, andD.B.
Wilson. 1986. Cyclosporin-inducedautoimmunity. Conditions
for expressing disease, requirement for intact thymus, and
potencyestimatesofautoimmune lymphocytes in drug-treated
rats. J. Exp Med. 164:1615.
7. Cheney, RT, and J. Sprent. 1985. Capacity of cyclosporine
to induce auto-graft-versus-host diseaseandimpair intrathymic
T cell differentiation. Transplant. Proc 17:528.
8. Sakaguchi, S., and N. Sakaguchi. 1988. Thymus and auto-
immunity. Transplantation of the thymus from cyclosporin
A-treated mice causes organ-specific autoimmune disease in
a thymic nude mice. J. Exp Med. 167:1479.
9. Kappler, J.W., N. Roehm, andP. Marrack. 1987 . Tcell toler-
398 Effect of Cyclosporin A on Intrathymic Clonal Deletion
ance by clonal elimination in the thymus. CeIL 49:273.
10. Kisielow, P., H. Bluthmann, U.D. Staerz, M. Steinmetz, and
H. VonBoehmer. 1988. Tolerancein T-cell-receptor transgenic
mice involves deletion of nonmature CD4`8' thymocytes.
Nature (Lon4 333:742.
11. Ogata, M., H. Matsubara, Y Takai, H. Kosaka, T. Katagiri,
H. Sano, K.Ishimura, H. Fujita, T Hamaoka, andH. Fujiwara.
1989. Capacities ofanewlyestablished thymic stromal cell clone
to express la antigens and to produce interleukin-6, colony-
stimulating factor, and thymic stroma-derived T -cell growth
factor.J. Leukocyte Biol. 45:69.
12. Sato, S., M. Ogata, H. Sano, Y. Mizushima, M. Muramatsu,
H.Doi, T Itoh, T Hamaoka, andH.Fujiwara. 1988. Thymic
stroma-derived T cell growth factor (TSTGF). II. Biochem-
ical and functional characterization. J. LeukocyteBiol. 44:149.
13. Mizushima, Y., M.Saitoh, M.Ogata, H. Kosaka, Y Tatsumi,
C. Kiyotaki, T Hamaoka, and H. Fujiwara. 1989. Thymic
stroma-derived T cell growth factor (TSTGF). IV Capacity
of TSTGF to promote the growth of L3T4 -Lyt-2- thymo-
cytesby synergywith phorbolmyristateacetate or various IL.
J. Immunol. 142:1195.
14. Kosaka, H., M. Ogata, I. Hikita, S. Maruo, S. Sugihara, H.
Matsubara, Y. Takai, T. Hamaoka, and H. Fujiwara. 1989.
Modelforclonal elimination in the thymus. Proc. Nad. Acad.
Sci. USA. 86:3773.
15. Jenkins, M.K., R.H. Schwartz, andD.M. Pardoll.1988. Effects
of cyclosporine A on T cell development andclonal deletion.
Science (Wash. DC). 241:1655.
16. Gao, E.-K., D. Lo, R. Cheney, O. Kanagawa, andJ. Sprent.
1988. Abnormal differentiation ofthymocytes in mice treated
with cyclosporine A. Nature (Lond.). 336:176.